{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:20:59Z","timestamp":1782379259606,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Elite PHD Program of Bethune Health Science Center, Jilin University","award":["470110000421"],"award-info":[{"award-number":["470110000421"]}]},{"name":"Graduate Innovation Fund of Jilin University","award":["2016106"],"award-info":[{"award-number":["2016106"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0982-3","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T22:30:23Z","timestamp":1511217023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The usefulness of chief complaints to predict severity, ventilator dependence, treatment option, and short-term outcome of patients with Guillain-Barr\u00e9 syndrome: a retrospective study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8194-5695","authenticated-orcid":false,"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunkui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"982_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014;137:33\u201343.","journal-title":"Brain"},{"key":"982_CR2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016;388:717\u201327.","journal-title":"Lancet"},{"key":"982_CR3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/YCO.0b013e3283586fd8","volume":"25","author":"R Stewart","year":"2012","unstructured":"Stewart R. Subjective cognitive impairment. Curr Opin Psychiatry. 2012;25:445\u201350.","journal-title":"Curr Opin Psychiatry"},{"key":"982_CR4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/2249-4863.130335","volume":"3","author":"A Mishra","year":"2014","unstructured":"Mishra A, Dave N, Mehta M. Fulminant Guillain-Barr\u00e9 syndrome with myocarditis. J Family Med Prim Care. 2014;3:84\u20135.","journal-title":"J Family Med Prim Care"},{"key":"982_CR5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.clineuro.2012.01.012","volume":"144","author":"C Parmentier","year":"2012","unstructured":"Parmentier C, Vandermeeren Y, Laloux P, Mormont E. Asymptomatic posterior reversible encephalopathy revealed by brain MRI in a case of axonal Guillain-Barr\u00e9 syndrome. Clin Neurol Neurosurg. 2012;144:1006\u20139.","journal-title":"Clin Neurol Neurosurg"},{"key":"982_CR6","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182904fcc","volume":"80","author":"B van den Berg","year":"2013","unstructured":"van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013;80:1650\u20134.","journal-title":"Neurology"},{"key":"982_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jns5.12050","volume":"19","author":"J Kalita","year":"2014","unstructured":"Kalita J, Misra UK, Goyal G, Das M. Guillain-Barr\u00e9 syndrome: subtypes and predictors of outcome from India. J Peripher Nerv Syst. 2014;19:36\u201343.","journal-title":"J Peripher Nerv Syst"},{"key":"982_CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2013.09.002","volume":"335","author":"R Verma","year":"2013","unstructured":"Verma R, Chaudhari TS, Raut TP, Garg RK. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS). J Neurol Sci. 2013;335:105\u201311.","journal-title":"J Neurol Sci"},{"key":"982_CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2377-13-95","volume":"13","author":"I Gonz\u00e1lez-Su\u00e1rez","year":"2013","unstructured":"Gonz\u00e1lez-Su\u00e1rez I, Sanz-Gallego I, Rodr\u00edguez de Rivera FJ, Arpa J. Guillain-Barr\u00e9 syndrome: natural history and prognostic factors: a retrospective review of 106 cases. BMC Neurol. 2013;13:95.","journal-title":"BMC Neurol"},{"key":"982_CR10","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","volume":"76","author":"C Walgaard","year":"2011","unstructured":"Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC. Early recognition of poor prognosis in Guillain-Barre syndrome. Neurology. 2011;76:968\u201375.","journal-title":"Neurology"},{"key":"982_CR11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e31820e7b62","volume":"76","author":"J Roodbol","year":"2011","unstructured":"Roodbol J, de Wit MC, Walgaard C, de Hoog M, Catsman-Berrevoets CE, Jacobs BC. Recognizing Guillain-Barr\u00e9 syndrome in preschool children. Neurology. 2011;76:807\u201310.","journal-title":"Neurology"},{"issue":"Suppl","key":"982_CR12","doi-asserted-by":"crossref","first-page":"s21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990;27(Suppl):s21\u20134.","journal-title":"Ann Neurol"},{"key":"982_CR13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2:750\u20133.","journal-title":"Lancet"},{"key":"982_CR14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.54.3.620","volume":"54","author":"R Van Koningsveld","year":"2000","unstructured":"Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Mech\u00e9 FG. Mild form of Guillain-Barr\u00e9 syndrome in an epidemiologic survey in The Netherlands. Neurology. 2000;54:620\u20135.","journal-title":"Neurology"},{"key":"982_CR15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.46.1.100","volume":"46","author":"V Bril","year":"1996","unstructured":"Bril V, Ilse WK, Pearce R, Dhanani A, Sutton D, Kong K. Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barr\u00e9 syndrome. Neurology. 1996;46:100\u20133.","journal-title":"Neurology"},{"key":"982_CR16","first-page":"64","volume":"21","author":"DJ Kim","year":"2015","unstructured":"Kim DJ, Lee J, Lee J, Kim MR, Ha IH. Guillain-Barr\u00e9 syndrome mistaken for a common spinal disorder: a case report. Altern Ther Health Med. 2015;21:64\u20137.","journal-title":"Altern Ther Health Med"},{"key":"982_CR17","first-page":"70","volume":"8","author":"V Aminzadeh","year":"2014","unstructured":"Aminzadeh V, Hassanzadeh RA. A report of guillain-Barr\u00e9 syndrome with myalgia and mild weakness. Iran J Child Neurol. 2014;8:70\u20132.","journal-title":"Iran J Child Neurol"},{"key":"982_CR18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA van Doom","year":"2008","unstructured":"van Doom PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome. Lancet Neurol. 2008;7:939\u201350.","journal-title":"Lancet Neurol"},{"key":"982_CR19","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/brain\/awu158","volume":"137","author":"JY Sung","year":"2014","unstructured":"Sung JY, Tani J, Park SB, Kiernan MC, Lin CS. Early identification of \u2018acute-onset\u2019 chronic inflammatory demyelinating polyneuropathy. Brain. 2014;137:2155\u201363.","journal-title":"Brain"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0982-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T22:30:29Z","timestamp":1511217029000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0982-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0982-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]},"article-number":"200"}}